Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PRECIGEN, INC. | 1,226,391 | reported | 13 Mar 2026 | tx 67+2,366,912−456,489 |
| BIOCRYST PHARMACEUTICALS INC | 18,903 | reported | 27 Feb 2026 | tx 8+50,163 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Mar 2026 | EXERCISE | PRECIGEN, INC. | 71,839 | — | |
| 13 Mar 2026 | EXERCISE | PRECIGEN, INC. | 71,839 | 0.00 USD | deriv |
| 10 Mar 2026 | GRANT_AWARD | PRECIGEN, INC. | 14,245 | 3.51 USD | |
| 10 Mar 2026 | GRANT_AWARD | PRECIGEN, INC. | 35,612 | 0.00 USD | deriv |
| 10 Mar 2026 | GRANT_AWARD | PRECIGEN, INC. | 41,073 | 0.00 USD | deriv |
| 27 Feb 2026 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 1,285 | 8.75 USD | |
| 28 Nov 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 1,566 | 7.18 USD | |
| 29 Aug 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 1,353 | 8.31 USD | |
| 12 Jun 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 12,500 | 0.00 USD | |
| 12 Jun 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 27,181 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 333 | 10.75 USD | |
| 02 May 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 1,866 | 0.00 USD | |
| 02 May 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 4,079 | 0.00 USD | deriv |
| 13 Mar 2025 | GRANT_AWARD | PRECIGEN, INC. | 28,735 | 1.74 USD | |
| 14 Mar 2025 | EXERCISE | PRECIGEN, INC. | 87,412 | — | |
| 13 Mar 2025 | GRANT_AWARD | PRECIGEN, INC. | 83,517 | 0.00 USD | deriv |
| 13 Mar 2025 | GRANT_AWARD | PRECIGEN, INC. | 71,839 | 0.00 USD | deriv |
| 14 Mar 2025 | EXERCISE | PRECIGEN, INC. | 87,412 | 0.00 USD | deriv |
| 14 Mar 2024 | GRANT_AWARD | PRECIGEN, INC. | 34,965 | 1.43 USD | |
| 14 Mar 2024 | GRANT_AWARD | PRECIGEN, INC. | 101,626 | 0.00 USD | deriv |
| 14 Mar 2024 | GRANT_AWARD | PRECIGEN, INC. | 87,412 | 0.00 USD | deriv |
| 09 Mar 2024 | EXERCISE | PRECIGEN, INC. | 106,837 | — | |
| 09 Mar 2024 | EXERCISE | PRECIGEN, INC. | 106,837 | 0.00 USD | deriv |
| 14 Aug 2023 | PURCHASE | PRECIGEN, INC. | 400,000 | 1.72 USD | |
| 09 Mar 2023 | GRANT_AWARD | PRECIGEN, INC. | 42,735 | 1.17 USD |